Navigation Links
Health of Patients with Nonalcoholic Steatohepatitis Improved Through Treatment with Anti-CD3 Antibodies
Date:11/7/2011

SAN FRANCISCO, Nov. 7, 2011  /PRNewswire/ -- Nonalcoholic steatohepatitis (NASH) is a major cause of cirrhosis and is growing in incidence in the United States. By treating patients with NASH with orally administered anti-CD3 monoclonal antibodies, researchers at Hadassah Medical Center and NasVax Ltd in Israel were able to improve clinical biomarkers for insulin resistance as well as liver enzyme levels.

The presentation of the study at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases (Monday, November 7), is on the results of a phase IIa blinded, placebo-controlled trial. Previous studies in animal models showed improvement in inflammation and autoimmunity. The purpose of this clinical trial was to determine safety and trends in clinical biomarkers and immune-modulation in patients with NASH.

The 36 subjects received one of three dosage levels of oral antibody immunotherapy or placebo once daily for 30 days, followed by an additional 30 days of observation. In addition to assessing a broad range of safety parameters, patients were tested for liver enzymes, glucose, lipid profile, oral glucose tolerance, serum cytokines, and regulatory T cells. Treatment was safe and very well tolerated, and no treatment-related adverse events were noted for any of the patients.

Because of the positive results of the study, lead researcher Dr. Mizrahi, said, "We think that these data are promising for the treatment of inflammatory diseases. The mechanism of action, which is the induction of regulatory T cells for the suppression of inflammation, is distinct from other therapies that have been investigated to date. Consequently we have intensified our effort to progress further clinical development in NASH and complete the ongoing Phase IIa trial in Hepatitis C."

Abstract title:

Oral administration of anti-C03 MAb to patients with NASH is safe, promotes regulatory T cells, decre
'/>"/>

SOURCE American Association for the Study of Liver Diseases (AASLD)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015  New product launches are critical events for ... educating thought leaders about new products, Medical Affairs is ... well a new therapy performs at launch. ... consulting leader Best Practices, LLC, critical aspects of launch ... are early stage thought leader (TL) interaction, successful TL ...
(Date:7/2/2015)... July 2, 2015 According to a ... (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), Application ... Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation Market ... to reach $6.20 Billion by 2020, at a CAGR of ... 8 4 market data T ...
(Date:7/2/2015)... July 2, 2015 Numotion,s Board of Directors ... that Tamas Feitel has joined the Company ... after a highly successful 18 year career at GE ... strategy, profitability, and productivity to result in significant industry ... was Chief Financial Officer for GE Healthcare Global Services, ...
Breaking Medicine Technology:Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Numotion Names Tamas Feitel Chief Financial Officer 2
... Upsher-Smith Laboratories, Inc. ( http://www.upsher-smith.com ) today announced ... of USL255, its once-daily, extended-release (ER) topiramate formulation, ... of Neurology (AAN) Meeting.  One of the posters ... of immediate-release (IR) topiramate at steady state, a ...
... Inc., the global leader in cold chain visibility ... (IATA) has deemed Sensitech,s full range of temperature ... with the 53rd edition of the IATA Dangerous ... the United Nations.   The size and lithium metal ...
Cached Medicine Technology:Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 2Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 3Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 4Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate 5Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar ... at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar ... points of investigating these types of cases. , Each year, New York State ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new Medical ... largest network of independent freestanding emergency rooms in the United States. , “We are ... Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James M. ...
(Date:7/3/2015)... Abilene, Texas (PRWEB) , ... July 03, 2015 , ... ... published a new article this week that he says will reveal biblical truth and ... article titled “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... is the first sweetFrog store located in Mississippi. The premium frozen yogurt chain was ... , The store, located at 104 Railroad Avenue, New Albany, MS 38652, will have ...
(Date:7/2/2015)... ... 2015 , ... Following the recent report by JAMA Internal Medicine ... overweight Americans, Samir Becic emphatically declared a war on obesity in the United States. ... said. "We must understand the magnitude of this discovery. For that reason, I am ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... Assembly (WHO), begins its annual meeting on Monday with delegations ... May 22nd to the 27th//. ,Brazil and Kenya ... the WHO assembly, for more funds to combat neglected diseases, ... to introduce a resolution to overhaul the way medical research ...
... is said that researchers are going to improve the already ... They are going to develop test kits which can help ... The skin tests are to be developed at the first ... ,By the end of 2008 these kits can be ...
... has carried a recent article on the benefits ... friendship ties, //suggesting that discussing others negative attitudes ... in friendship. ,Research shows that sharing ... it promotes closeness and friendship. In their study, ...
... Ramadoss expressed satisfaction at India’s efforts to effectively curtail the ... chicken and eggs are absolutely safe to eat, since there ... is perfect to eat chickens and eggs. The poultry should ... generally boiled at 100 degrees as it is fried in ...
... Stroke Alliance for Europe (SAFE) today announced the ,launch ... research ,project, revealed at the European Stroke Conference (ESC) ... patients and caregivers, with the first results ,expected in ... Stroke Alliance for Europe (SAFE) said, ‘We ,are excited ...
... a brand new internet-based ,television show//: PharmaVentures Business ... says, ‘This show, the first in a ,monthly ... sectors with insightful analysis and debate covering major ... to topical interviews with senior ,executives and experts, ...
Cached Medicine News:Health News:Global Stroke Survey Launched 2Health News:PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show 2
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... A crisp 2.3 million pixel ... the retinal surface for all ... disc evaluation for glaucoma to ... way to provide filmless, instant ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: